Introduction In aortic valve disease, several interventions are available. In young people who are still growing, or ...
My husband has been suffering from tinnitus for a couple of years now. His primary care physician referred him to an ...
Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...
The ACC issued new guidance for managing common pediatric left-to-right shunts, including ASD, VSD, and PDA, in the ...
Our cover story this month, which outlines the issues surrounding tricuspid valve (TV) dysfunction, is worth a careful read. The story highlights the etiology, diagnosis and recent evolution of ...
The US Food and Drug Administration has approved the Trilogy transcatheter heart valve (JenaValve) for patients with symptomatic severe aortic regurgitation at high risk for surgery, according to an ...
JenaValve has secured the FDA’s approval for its minimally invasive heart implant, making it the first to claim a U.S. green light to treat severe backflow through the aortic valve. And it gets to ...
The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, device maker JenaValve Technology announced. This approval makes Trilogy the ...
EW shares jump 22.1% in a year as growth in TMTT and strong adoption of PASCAL, EVOQUE and SAPIEN technologies fuel momentum.
Background Thoracic aortic aneurysm is a life-threatening disease due to the risk for acute aortic syndromes, and subjects with dilated ascending aortas are recommended surveillance imaging to assess ...
Chronic aortic regurgitation (AR) is associated with significant cardiac remodeling, but the prevalence and prognostic impact of extravalvular cardiac damage remain unexplored. Adults with moderate or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results